• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Hemispherx Biopharma, Inc. (HEB)

    -NYSE MKT
    0.23 Down 0.00(0.88%) Mar 27, 4:01PM EDT
    Add to Portfolio
    Prev Close:0.23
    Open:0.23
    Bid:0.22 x 100
    Ask:0.25 x 900
    1y Target Est:3.00
    Beta:0.32
    Next Earnings Date:N/A
    Day's Range:0.23 - 0.23
    52wk Range:0.21 - 0.42
    Volume:919,612
    Avg Vol (3m):1,906,200
    Market Cap:45.01M
    P/E (ttm):N/A
    EPS (ttm):-0.09
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for HEB

    Comparison

    Symbol% ChgMkt Cap
    HEBDown 0.88%45.01M
    GILDDown 0.07%150.43B
    MRKUp 0.26%163.91B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):235.26
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Dec-14) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Hemispherx Biopharma, Inc., a specialty pharmaceutical company, is engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback